

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.00503697 |
| 2 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.62627579 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.51858854 |
| 4 | neurotransmitter-gated ion channel clustering (GO:0072578) | 5.45355821 |
| 5 | vocalization behavior (GO:0071625) | 5.38617795 |
| 6 | synaptic transmission, dopaminergic (GO:0001963) | 5.18001726 |
| 7 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.16249529 |
| 8 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.15565337 |
| 9 | locomotory exploration behavior (GO:0035641) | 5.15071541 |
| 10 | cellular potassium ion homeostasis (GO:0030007) | 5.00103718 |
| 11 | prepulse inhibition (GO:0060134) | 4.93655010 |
| 12 | protein localization to synapse (GO:0035418) | 4.91972234 |
| 13 | behavioral response to cocaine (GO:0048148) | 4.90545093 |
| 14 | synaptic vesicle exocytosis (GO:0016079) | 4.82830742 |
| 15 | neuron-neuron synaptic transmission (GO:0007270) | 4.75251351 |
| 16 | synaptic vesicle maturation (GO:0016188) | 4.74298632 |
| 17 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.73623699 |
| 18 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.69601309 |
| 19 | striatum development (GO:0021756) | 4.69354151 |
| 20 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.63945763 |
| 21 | regulation of synapse structural plasticity (GO:0051823) | 4.63023715 |
| 22 | sodium ion export (GO:0071436) | 4.58753266 |
| 23 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.52374713 |
| 24 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.51895826 |
| 25 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 4.50957744 |
| 26 | glutamate secretion (GO:0014047) | 4.47569017 |
| 27 | neuron cell-cell adhesion (GO:0007158) | 4.46790339 |
| 28 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 4.45345502 |
| 29 | neuronal action potential propagation (GO:0019227) | 4.42030649 |
| 30 | synaptic transmission, glutamatergic (GO:0035249) | 4.40026174 |
| 31 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.35712749 |
| 32 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.35203072 |
| 33 | glutamate receptor signaling pathway (GO:0007215) | 4.33054240 |
| 34 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.29969064 |
| 35 | positive regulation of neurotransmitter secretion (GO:0001956) | 4.22780172 |
| 36 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.22511256 |
| 37 | auditory behavior (GO:0031223) | 4.18516212 |
| 38 | L-amino acid import (GO:0043092) | 4.16718626 |
| 39 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 4.12894661 |
| 40 | long-term synaptic potentiation (GO:0060291) | 4.12205729 |
| 41 | presynaptic membrane assembly (GO:0097105) | 4.10548283 |
| 42 | response to histamine (GO:0034776) | 4.09784942 |
| 43 | regulation of glutamate secretion (GO:0014048) | 4.08543434 |
| 44 | regulation of postsynaptic membrane potential (GO:0060078) | 4.08037752 |
| 45 | response to amphetamine (GO:0001975) | 4.08017916 |
| 46 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 4.07117075 |
| 47 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 4.07117075 |
| 48 | positive regulation of neurotransmitter transport (GO:0051590) | 4.05858471 |
| 49 | neurotransmitter secretion (GO:0007269) | 4.02476898 |
| 50 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.02450692 |
| 51 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.01688299 |
| 52 | positive regulation of membrane potential (GO:0045838) | 4.01590782 |
| 53 | regulation of synaptic vesicle transport (GO:1902803) | 4.00974000 |
| 54 | membrane depolarization during action potential (GO:0086010) | 3.98642335 |
| 55 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.95242459 |
| 56 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.94566119 |
| 57 | regulation of synapse maturation (GO:0090128) | 3.92253304 |
| 58 | long-term memory (GO:0007616) | 3.90181485 |
| 59 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.88051968 |
| 60 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.86692161 |
| 61 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.85899744 |
| 62 | regulation of synaptic plasticity (GO:0048167) | 3.85890706 |
| 63 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.84889839 |
| 64 | presynaptic membrane organization (GO:0097090) | 3.84871968 |
| 65 | exploration behavior (GO:0035640) | 3.81118561 |
| 66 | behavioral fear response (GO:0001662) | 3.80031117 |
| 67 | behavioral defense response (GO:0002209) | 3.80031117 |
| 68 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.79651565 |
| 69 | transmission of nerve impulse (GO:0019226) | 3.76557368 |
| 70 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.74579683 |
| 71 | regulation of female receptivity (GO:0045924) | 3.73594855 |
| 72 | regulation of cell communication by electrical coupling (GO:0010649) | 3.72486870 |
| 73 | positive regulation of dendritic spine development (GO:0060999) | 3.71367315 |
| 74 | positive regulation of synapse maturation (GO:0090129) | 3.69842364 |
| 75 | postsynaptic membrane organization (GO:0001941) | 3.69147692 |
| 76 | dopamine receptor signaling pathway (GO:0007212) | 3.64871291 |
| 77 | regulation of neurotransmitter uptake (GO:0051580) | 3.64036514 |
| 78 | mechanosensory behavior (GO:0007638) | 3.63696312 |
| 79 | response to auditory stimulus (GO:0010996) | 3.59556566 |
| 80 | negative regulation of amino acid transport (GO:0051956) | 3.58958764 |
| 81 | dendritic spine morphogenesis (GO:0060997) | 3.55875796 |
| 82 | potassium ion import (GO:0010107) | 3.54808439 |
| 83 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.51991235 |
| 84 | fear response (GO:0042596) | 3.51878605 |
| 85 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.51236996 |
| 86 | cAMP catabolic process (GO:0006198) | 3.51062090 |
| 87 | amino acid import (GO:0043090) | 3.50927036 |
| 88 | negative regulation of dendrite development (GO:2000171) | 3.49570773 |
| 89 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.48933167 |
| 90 | neuromuscular synaptic transmission (GO:0007274) | 3.47674763 |
| 91 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.47034684 |
| 92 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.46473719 |
| 93 | female mating behavior (GO:0060180) | 3.45887555 |
| 94 | neuromuscular process controlling balance (GO:0050885) | 3.45631969 |
| 95 | regulation of dendritic spine development (GO:0060998) | 3.45116197 |
| 96 | visual learning (GO:0008542) | 3.43243100 |
| 97 | regulation of neurotransmitter levels (GO:0001505) | 3.43085952 |
| 98 | long term synaptic depression (GO:0060292) | 3.41453501 |
| 99 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.39301613 |
| 100 | synaptic vesicle endocytosis (GO:0048488) | 3.38226603 |
| 101 | gamma-aminobutyric acid transport (GO:0015812) | 3.37012605 |
| 102 | regulation of neurotransmitter transport (GO:0051588) | 3.35547784 |
| 103 | membrane depolarization (GO:0051899) | 3.34930377 |
| 104 | membrane hyperpolarization (GO:0060081) | 3.34234438 |
| 105 | peristalsis (GO:0030432) | 3.33850362 |
| 106 | positive regulation of synaptic transmission (GO:0050806) | 3.33682383 |
| 107 | learning (GO:0007612) | 3.33622166 |
| 108 | potassium ion homeostasis (GO:0055075) | 3.33132420 |
| 109 | regulation of neurotransmitter secretion (GO:0046928) | 3.32640928 |
| 110 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.31414273 |
| 111 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.31414273 |
| 112 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.29272281 |
| 113 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.29260440 |
| 114 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.28692260 |
| 115 | cell communication by electrical coupling (GO:0010644) | 3.27601087 |
| 116 | visual behavior (GO:0007632) | 3.24945125 |
| 117 | cerebellar granule cell differentiation (GO:0021707) | 3.24189542 |
| 118 | regulation of protein kinase A signaling (GO:0010738) | 3.23812877 |
| 119 | neuronal ion channel clustering (GO:0045161) | 3.21729587 |
| 120 | cellular sodium ion homeostasis (GO:0006883) | 3.20862201 |
| 121 | mating behavior (GO:0007617) | 3.19205863 |
| 122 | adenosine receptor signaling pathway (GO:0001973) | 3.19092280 |
| 123 | detection of calcium ion (GO:0005513) | 3.18791859 |
| 124 | activation of protein kinase A activity (GO:0034199) | 3.17747388 |
| 125 | cell communication involved in cardiac conduction (GO:0086065) | 3.12719533 |
| 126 | proline transport (GO:0015824) | 3.11956081 |
| 127 | serotonin metabolic process (GO:0042428) | 3.11683136 |
| 128 | neurotransmitter transport (GO:0006836) | 3.11340577 |
| 129 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.11157400 |
| 130 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.11157400 |
| 131 | regulation of vesicle fusion (GO:0031338) | 3.09790042 |
| 132 | layer formation in cerebral cortex (GO:0021819) | 3.09650533 |
| 133 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.05138422 |
| 134 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.02387036 |
| 135 | regulation of ARF protein signal transduction (GO:0032012) | 3.01136041 |
| 136 | axon ensheathment in central nervous system (GO:0032291) | 2.99521322 |
| 137 | central nervous system myelination (GO:0022010) | 2.99521322 |
| 138 | neuromuscular process (GO:0050905) | 2.99437533 |
| 139 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.99422896 |
| 140 | regulation of membrane repolarization (GO:0060306) | 2.97781997 |
| 141 | response to parathyroid hormone (GO:0071107) | 2.94331652 |
| 142 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.94318431 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.49934234 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.24918019 |
| 3 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.36508803 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.24915664 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.18486262 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.10444599 |
| 7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.72628004 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.69209616 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.67593516 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.67593516 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.63160569 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.59788684 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.49809515 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.49688878 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.45805000 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.45304068 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.42196788 |
| 18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.23349016 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.20803737 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.19419272 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.15751956 |
| 22 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.14044595 |
| 23 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.14021678 |
| 24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.11295984 |
| 25 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.06916717 |
| 26 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.03093311 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.01578472 |
| 28 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.97102977 |
| 29 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.86242115 |
| 30 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.80388599 |
| 31 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.79093034 |
| 32 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.76181273 |
| 33 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.76150982 |
| 34 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.71429653 |
| 35 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.69679881 |
| 36 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.66926307 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.64525800 |
| 38 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.57953689 |
| 39 | P300_19829295_ChIP-Seq_ESCs_Human | 1.56314310 |
| 40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.54702564 |
| 41 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.54413035 |
| 42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.51044179 |
| 43 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.49673305 |
| 44 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.48841333 |
| 45 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.46033210 |
| 46 | * NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.44535928 |
| 47 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.36018987 |
| 48 | STAT3_23295773_ChIP-Seq_U87_Human | 1.33341962 |
| 49 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.29451312 |
| 50 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27358188 |
| 51 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.26507260 |
| 52 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.26054069 |
| 53 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.24772405 |
| 54 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.24118075 |
| 55 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22927608 |
| 56 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22340505 |
| 57 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.22036560 |
| 58 | AR_19668381_ChIP-Seq_PC3_Human | 1.20276401 |
| 59 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.19923520 |
| 60 | TCF4_23295773_ChIP-Seq_U87_Human | 1.19801036 |
| 61 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.19550477 |
| 62 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17779968 |
| 63 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.17388090 |
| 64 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.16333401 |
| 65 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.16100270 |
| 66 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.15666139 |
| 67 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.15620129 |
| 68 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15482977 |
| 69 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15305556 |
| 70 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.14834765 |
| 71 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.13208192 |
| 72 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.12815166 |
| 73 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.12775533 |
| 74 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.12761479 |
| 75 | FUS_26573619_Chip-Seq_HEK293_Human | 1.12725186 |
| 76 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.12176265 |
| 77 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.11333692 |
| 78 | TP53_16413492_ChIP-PET_HCT116_Human | 1.08764485 |
| 79 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07635084 |
| 80 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.06038302 |
| 81 | RXR_22108803_ChIP-Seq_LS180_Human | 1.05376532 |
| 82 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.05291485 |
| 83 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05029694 |
| 84 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04651287 |
| 85 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.04528409 |
| 86 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.03868027 |
| 87 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03452077 |
| 88 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.03450537 |
| 89 | KDM2B_26808549_Chip-Seq_REH_Human | 1.02355960 |
| 90 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.01349074 |
| 91 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.01305967 |
| 92 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.00359041 |
| 93 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.98469561 |
| 94 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.97984594 |
| 95 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97835099 |
| 96 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.97541739 |
| 97 | KDM2B_26808549_Chip-Seq_K562_Human | 0.97518050 |
| 98 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.96919852 |
| 99 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.96916721 |
| 100 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.96711421 |
| 101 | JUN_21703547_ChIP-Seq_K562_Human | 0.96326528 |
| 102 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.95228694 |
| 103 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.94849313 |
| 104 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.94643065 |
| 105 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.94414100 |
| 106 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.93865350 |
| 107 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93860196 |
| 108 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.93860196 |
| 109 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93679668 |
| 110 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92812045 |
| 111 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91025647 |
| 112 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90520149 |
| 113 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.90283012 |
| 114 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.90214208 |
| 115 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.90022157 |
| 116 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88840913 |
| 117 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.88557966 |
| 118 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.87904918 |
| 119 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.87832268 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002822_catalepsy | 6.55418074 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 6.36093151 |
| 3 | MP0003880_abnormal_central_pattern | 5.31468523 |
| 4 | * MP0003635_abnormal_synaptic_transmissio | 4.23819789 |
| 5 | MP0009745_abnormal_behavioral_response | 3.92024653 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.62431675 |
| 7 | MP0004270_analgesia | 3.55162803 |
| 8 | MP0002064_seizures | 3.23496727 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.11234349 |
| 10 | MP0009046_muscle_twitch | 3.09219127 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 3.03426302 |
| 12 | MP0001486_abnormal_startle_reflex | 2.76615826 |
| 13 | MP0002272_abnormal_nervous_system | 2.61708587 |
| 14 | MP0001529_abnormal_vocalization | 2.36138907 |
| 15 | MP0002736_abnormal_nociception_after | 2.31569516 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.27369357 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.23559911 |
| 18 | MP0005423_abnormal_somatic_nervous | 2.20011094 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.03882074 |
| 20 | MP0005386_behavior/neurological_phenoty | 2.03114021 |
| 21 | MP0004924_abnormal_behavior | 2.03114021 |
| 22 | MP0005646_abnormal_pituitary_gland | 1.96074390 |
| 23 | MP0002067_abnormal_sensory_capabilities | 1.94523675 |
| 24 | MP0003879_abnormal_hair_cell | 1.91396459 |
| 25 | MP0000749_muscle_degeneration | 1.90550923 |
| 26 | MP0009780_abnormal_chondrocyte_physiolo | 1.88801297 |
| 27 | MP0001970_abnormal_pain_threshold | 1.83628595 |
| 28 | MP0002733_abnormal_thermal_nociception | 1.80756326 |
| 29 | MP0002735_abnormal_chemical_nociception | 1.80467293 |
| 30 | MP0008569_lethality_at_weaning | 1.78295327 |
| 31 | MP0002909_abnormal_adrenal_gland | 1.77265288 |
| 32 | MP0002557_abnormal_social/conspecific_i | 1.72922551 |
| 33 | MP0001984_abnormal_olfaction | 1.72622085 |
| 34 | MP0001188_hyperpigmentation | 1.61966204 |
| 35 | MP0005409_darkened_coat_color | 1.57918627 |
| 36 | MP0004811_abnormal_neuron_physiology | 1.54850224 |
| 37 | MP0002184_abnormal_innervation | 1.44079215 |
| 38 | MP0000778_abnormal_nervous_system | 1.39416326 |
| 39 | MP0003633_abnormal_nervous_system | 1.37718751 |
| 40 | MP0003787_abnormal_imprinting | 1.37189676 |
| 41 | MP0001905_abnormal_dopamine_level | 1.36807502 |
| 42 | MP0003329_amyloid_beta_deposits | 1.35245860 |
| 43 | MP0002066_abnormal_motor_capabilities/c | 1.34610686 |
| 44 | MP0004130_abnormal_muscle_cell | 1.28851697 |
| 45 | MP0003646_muscle_fatigue | 1.28300198 |
| 46 | MP0008872_abnormal_physiological_respon | 1.27594971 |
| 47 | MP0000955_abnormal_spinal_cord | 1.24417949 |
| 48 | MP0004885_abnormal_endolymph | 1.20203125 |
| 49 | MP0008874_decreased_physiological_sensi | 1.19826351 |
| 50 | MP0004036_abnormal_muscle_relaxation | 1.19790343 |
| 51 | MP0002882_abnormal_neuron_morphology | 1.19092828 |
| 52 | MP0000747_muscle_weakness | 1.18430227 |
| 53 | MP0001502_abnormal_circadian_rhythm | 1.15188196 |
| 54 | MP0001986_abnormal_taste_sensitivity | 1.10768640 |
| 55 | MP0000759_abnormal_skeletal_muscle | 1.08877365 |
| 56 | MP0003631_nervous_system_phenotype | 1.08413774 |
| 57 | MP0004142_abnormal_muscle_tone | 1.01398981 |
| 58 | MP0003075_altered_response_to | 0.99776747 |
| 59 | MP0002106_abnormal_muscle_physiology | 0.98425812 |
| 60 | MP0000013_abnormal_adipose_tissue | 0.98155384 |
| 61 | MP0004858_abnormal_nervous_system | 0.97470574 |
| 62 | MP0004085_abnormal_heartbeat | 0.96335514 |
| 63 | MP0002069_abnormal_eating/drinking_beha | 0.96039741 |
| 64 | MP0004087_abnormal_muscle_fiber | 0.95313343 |
| 65 | MP0006276_abnormal_autonomic_nervous | 0.94817093 |
| 66 | MP0000751_myopathy | 0.94011195 |
| 67 | MP0002152_abnormal_brain_morphology | 0.93626022 |
| 68 | MP0005620_abnormal_muscle_contractility | 0.92408226 |
| 69 | MP0001177_atelectasis | 0.91299799 |
| 70 | MP0003123_paternal_imprinting | 0.90098802 |
| 71 | MP0002876_abnormal_thyroid_physiology | 0.89080099 |
| 72 | MP0004145_abnormal_muscle_electrophysio | 0.87103154 |
| 73 | MP0005535_abnormal_body_temperature | 0.84967397 |
| 74 | MP0004742_abnormal_vestibular_system | 0.84137990 |
| 75 | MP0005167_abnormal_blood-brain_barrier | 0.83927253 |
| 76 | MP0008961_abnormal_basal_metabolism | 0.83383102 |
| 77 | MP0004147_increased_porphyrin_level | 0.82319930 |
| 78 | MP0005645_abnormal_hypothalamus_physiol | 0.82310402 |
| 79 | MP0005369_muscle_phenotype | 0.80041079 |
| 80 | MP0002269_muscular_atrophy | 0.77158224 |
| 81 | MP0002229_neurodegeneration | 0.76825221 |
| 82 | MP0001485_abnormal_pinna_reflex | 0.75330454 |
| 83 | MP0000569_abnormal_digit_pigmentation | 0.74939961 |
| 84 | MP0002638_abnormal_pupillary_reflex | 0.74596576 |
| 85 | MP0008877_abnormal_DNA_methylation | 0.73224773 |
| 86 | MP0004084_abnormal_cardiac_muscle | 0.73165171 |
| 87 | MP0005551_abnormal_eye_electrophysiolog | 0.72139693 |
| 88 | MP0002332_abnormal_exercise_endurance | 0.71630201 |
| 89 | MP0010386_abnormal_urinary_bladder | 0.69686047 |
| 90 | MP0000920_abnormal_myelination | 0.68812633 |
| 91 | MP0000631_abnormal_neuroendocrine_gland | 0.68390493 |
| 92 | MP0002837_dystrophic_cardiac_calcinosis | 0.68226469 |
| 93 | MP0001963_abnormal_hearing_physiology | 0.68090253 |
| 94 | MP0003690_abnormal_glial_cell | 0.67989060 |
| 95 | MP0004510_myositis | 0.64785509 |
| 96 | MP0005171_absent_coat_pigmentation | 0.64767956 |
| 97 | MP0001664_abnormal_digestion | 0.64721750 |
| 98 | MP0010234_abnormal_vibrissa_follicle | 0.63021742 |
| 99 | MP0005499_abnormal_olfactory_system | 0.60811465 |
| 100 | MP0005394_taste/olfaction_phenotype | 0.60811465 |
| 101 | MP0002090_abnormal_vision | 0.58111514 |
| 102 | MP0003122_maternal_imprinting | 0.57181281 |
| 103 | MP0004484_altered_response_of | 0.57068694 |
| 104 | MP0000750_abnormal_muscle_regeneration | 0.56954020 |
| 105 | MP0003121_genomic_imprinting | 0.56272591 |
| 106 | MP0003632_abnormal_nervous_system | 0.56106668 |
| 107 | MP0003137_abnormal_impulse_conducting | 0.55959965 |
| 108 | MP0000604_amyloidosis | 0.55231160 |
| 109 | MP0004215_abnormal_myocardial_fiber | 0.54333338 |
| 110 | MP0003045_fibrosis | 0.54260201 |
| 111 | MP0001299_abnormal_eye_distance/ | 0.52966556 |
| 112 | MP0002752_abnormal_somatic_nervous | 0.52522398 |
| 113 | MP0004043_abnormal_pH_regulation | 0.52412961 |
| 114 | MP0001943_abnormal_respiration | 0.51710218 |
| 115 | MP0003634_abnormal_glial_cell | 0.51228511 |
| 116 | MP0003956_abnormal_body_size | 0.48134347 |
| 117 | MP0004233_abnormal_muscle_weight | 0.45934788 |
| 118 | MP0010769_abnormal_survival | 0.45860233 |
| 119 | MP0010770_preweaning_lethality | 0.44816835 |
| 120 | MP0002082_postnatal_lethality | 0.44816835 |
| 121 | MP0001765_abnormal_ion_homeostasis | 0.43801298 |
| 122 | MP0010768_mortality/aging | 0.43131977 |
| 123 | MP0005166_decreased_susceptibility_to | 0.42750197 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 9.41933873 |
| 2 | Myokymia (HP:0002411) | 7.81049504 |
| 3 | Focal seizures (HP:0007359) | 6.34189071 |
| 4 | Epileptic encephalopathy (HP:0200134) | 5.73261862 |
| 5 | Hyperventilation (HP:0002883) | 5.00792736 |
| 6 | Broad-based gait (HP:0002136) | 4.64277370 |
| 7 | Atonic seizures (HP:0010819) | 4.61724138 |
| 8 | Febrile seizures (HP:0002373) | 4.60212172 |
| 9 | Visual hallucinations (HP:0002367) | 4.56933434 |
| 10 | Nemaline bodies (HP:0003798) | 4.44275533 |
| 11 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.42358319 |
| 12 | Muscle fiber inclusion bodies (HP:0100299) | 4.41906451 |
| 13 | Poor eye contact (HP:0000817) | 4.25580939 |
| 14 | Absence seizures (HP:0002121) | 4.18781648 |
| 15 | Gaze-evoked nystagmus (HP:0000640) | 4.16662638 |
| 16 | Dialeptic seizures (HP:0011146) | 4.03661353 |
| 17 | Generalized tonic-clonic seizures (HP:0002069) | 3.94232535 |
| 18 | Exercise-induced myalgia (HP:0003738) | 3.77680809 |
| 19 | Annular pancreas (HP:0001734) | 3.77392183 |
| 20 | Abnormal social behavior (HP:0012433) | 3.70277455 |
| 21 | Impaired social interactions (HP:0000735) | 3.70277455 |
| 22 | Progressive cerebellar ataxia (HP:0002073) | 3.69963109 |
| 23 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.66690399 |
| 24 | Dysdiadochokinesis (HP:0002075) | 3.57095176 |
| 25 | Distal arthrogryposis (HP:0005684) | 3.56703221 |
| 26 | Akinesia (HP:0002304) | 3.51358139 |
| 27 | Dysmetric saccades (HP:0000641) | 3.48711232 |
| 28 | Amblyopia (HP:0000646) | 3.42416939 |
| 29 | Torticollis (HP:0000473) | 3.41229757 |
| 30 | Action tremor (HP:0002345) | 3.37302865 |
| 31 | Stereotypic behavior (HP:0000733) | 3.30849331 |
| 32 | Resting tremor (HP:0002322) | 3.27740920 |
| 33 | Anxiety (HP:0000739) | 3.27114702 |
| 34 | Depression (HP:0000716) | 3.22923903 |
| 35 | Type 1 muscle fiber predominance (HP:0003803) | 3.22576924 |
| 36 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.19449581 |
| 37 | Truncal ataxia (HP:0002078) | 3.15289703 |
| 38 | Scanning speech (HP:0002168) | 3.12212389 |
| 39 | Dysmetria (HP:0001310) | 3.10809945 |
| 40 | Exercise-induced muscle cramps (HP:0003710) | 3.08325482 |
| 41 | Focal dystonia (HP:0004373) | 3.05457088 |
| 42 | Hyporeflexia of lower limbs (HP:0002600) | 2.98462944 |
| 43 | Impaired smooth pursuit (HP:0007772) | 2.97565991 |
| 44 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.91019730 |
| 45 | Ankle clonus (HP:0011448) | 2.89524388 |
| 46 | Calf muscle hypertrophy (HP:0008981) | 2.89362686 |
| 47 | Craniofacial dystonia (HP:0012179) | 2.88093114 |
| 48 | Abnormal eating behavior (HP:0100738) | 2.86373699 |
| 49 | Drooling (HP:0002307) | 2.83210125 |
| 50 | Excessive salivation (HP:0003781) | 2.83210125 |
| 51 | Sudden death (HP:0001699) | 2.82881314 |
| 52 | Subaortic stenosis (HP:0001682) | 2.81678869 |
| 53 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.81678869 |
| 54 | Round ear (HP:0100830) | 2.78813143 |
| 55 | Protruding tongue (HP:0010808) | 2.74410117 |
| 56 | Impaired vibratory sensation (HP:0002495) | 2.67954377 |
| 57 | Urinary urgency (HP:0000012) | 2.66437078 |
| 58 | Postural instability (HP:0002172) | 2.65988986 |
| 59 | Epileptiform EEG discharges (HP:0011182) | 2.65805517 |
| 60 | Inability to walk (HP:0002540) | 2.50776707 |
| 61 | Bundle branch block (HP:0011710) | 2.49833982 |
| 62 | Lower limb amyotrophy (HP:0007210) | 2.47905998 |
| 63 | Difficulty running (HP:0009046) | 2.45229609 |
| 64 | Status epilepticus (HP:0002133) | 2.44244309 |
| 65 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.44117686 |
| 66 | Bradykinesia (HP:0002067) | 2.39263250 |
| 67 | Ankyloglossia (HP:0010296) | 2.37654392 |
| 68 | Genetic anticipation (HP:0003743) | 2.37543503 |
| 69 | EEG with generalized epileptiform discharges (HP:0011198) | 2.37218185 |
| 70 | Fetal akinesia sequence (HP:0001989) | 2.36998453 |
| 71 | Insidious onset (HP:0003587) | 2.36398001 |
| 72 | Termporal pattern (HP:0011008) | 2.36398001 |
| 73 | Muscle fiber splitting (HP:0003555) | 2.36256119 |
| 74 | Myotonia (HP:0002486) | 2.35433670 |
| 75 | Supranuclear gaze palsy (HP:0000605) | 2.35281554 |
| 76 | Spastic gait (HP:0002064) | 2.34697750 |
| 77 | Incomplete penetrance (HP:0003829) | 2.34193148 |
| 78 | Absent speech (HP:0001344) | 2.32935598 |
| 79 | Progressive inability to walk (HP:0002505) | 2.28131210 |
| 80 | Cerebral hypomyelination (HP:0006808) | 2.27842230 |
| 81 | Blue irides (HP:0000635) | 2.26684859 |
| 82 | Abnormality of the lower motor neuron (HP:0002366) | 2.26289488 |
| 83 | EMG: myopathic abnormalities (HP:0003458) | 2.25977103 |
| 84 | Calcaneovalgus deformity (HP:0001848) | 2.25293483 |
| 85 | Myopathic facies (HP:0002058) | 2.24675526 |
| 86 | Hemiparesis (HP:0001269) | 2.24269455 |
| 87 | Pointed chin (HP:0000307) | 2.24005855 |
| 88 | Papilledema (HP:0001085) | 2.21583618 |
| 89 | Hypsarrhythmia (HP:0002521) | 2.20570386 |
| 90 | Ulnar deviation of the wrist (HP:0003049) | 2.17271070 |
| 91 | Prolonged QT interval (HP:0001657) | 2.16514667 |
| 92 | Malignant hyperthermia (HP:0002047) | 2.14611418 |
| 93 | Popliteal pterygium (HP:0009756) | 2.14493368 |
| 94 | EMG: neuropathic changes (HP:0003445) | 2.14108087 |
| 95 | Abnormality of the calf musculature (HP:0001430) | 2.13731957 |
| 96 | Tetraplegia (HP:0002445) | 2.13352338 |
| 97 | Clonus (HP:0002169) | 2.10504979 |
| 98 | Intention tremor (HP:0002080) | 2.08367060 |
| 99 | Distal lower limb amyotrophy (HP:0008944) | 2.07980067 |
| 100 | Abnormal EKG (HP:0003115) | 2.04391707 |
| 101 | Mutism (HP:0002300) | 2.03645664 |
| 102 | Gait ataxia (HP:0002066) | 2.01195023 |
| 103 | Deeply set eye (HP:0000490) | 1.98053201 |
| 104 | Hemiplegia (HP:0002301) | 1.97726223 |
| 105 | Deformed tarsal bones (HP:0008119) | 1.96248328 |
| 106 | Abnormality of saccadic eye movements (HP:0000570) | 1.95656368 |
| 107 | Limb dystonia (HP:0002451) | 1.94738926 |
| 108 | Lower limb muscle weakness (HP:0007340) | 1.94714974 |
| 109 | Frequent falls (HP:0002359) | 1.94123847 |
| 110 | Cerebral inclusion bodies (HP:0100314) | 1.92160408 |
| 111 | Generalized myoclonic seizures (HP:0002123) | 1.91967116 |
| 112 | Neuronal loss in central nervous system (HP:0002529) | 1.91502708 |
| 113 | Diplopia (HP:0000651) | 1.89353902 |
| 114 | Abnormality of binocular vision (HP:0011514) | 1.89353902 |
| 115 | Lower limb asymmetry (HP:0100559) | 1.87016049 |
| 116 | Spinal canal stenosis (HP:0003416) | 1.84679198 |
| 117 | Generalized hypopigmentation of hair (HP:0011358) | 1.84653273 |
| 118 | Megalencephaly (HP:0001355) | 1.84394913 |
| 119 | Abnormality of the corticospinal tract (HP:0002492) | 1.83482678 |
| 120 | Abnormality of salivation (HP:0100755) | 1.83368459 |
| 121 | Thickened helices (HP:0000391) | 1.82187227 |
| 122 | Short chin (HP:0000331) | 1.80299725 |
| 123 | Gait imbalance (HP:0002141) | 1.79619536 |
| 124 | Abnormality of oral frenula (HP:0000190) | 1.79112307 |
| 125 | Obstructive sleep apnea (HP:0002870) | 1.77534110 |
| 126 | Abnormality of the periventricular white matter (HP:0002518) | 1.77010901 |
| 127 | Inappropriate behavior (HP:0000719) | 1.76267495 |
| 128 | Fair hair (HP:0002286) | 1.75695529 |
| 129 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.75630581 |
| 130 | Absent/shortened dynein arms (HP:0200106) | 1.75630581 |
| 131 | Gastroesophageal reflux (HP:0002020) | 1.75440351 |
| 132 | Autism (HP:0000717) | 1.71531366 |
| 133 | Neurofibrillary tangles (HP:0002185) | 1.66454764 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 6.59790031 |
| 2 | NTRK3 | 4.30468713 |
| 3 | CASK | 3.61523192 |
| 4 | DAPK2 | 3.34220226 |
| 5 | MAP3K9 | 3.08388314 |
| 6 | RIPK4 | 2.80604550 |
| 7 | MAP3K4 | 2.44061301 |
| 8 | OBSCN | 2.39808050 |
| 9 | PHKG1 | 2.32843730 |
| 10 | PHKG2 | 2.32843730 |
| 11 | DAPK1 | 2.18225300 |
| 12 | CAMKK2 | 2.15355016 |
| 13 | MAP2K7 | 2.13239980 |
| 14 | KSR2 | 2.11903196 |
| 15 | MINK1 | 2.10011218 |
| 16 | CAMKK1 | 2.08323995 |
| 17 | KSR1 | 2.01642760 |
| 18 | TNIK | 1.86566438 |
| 19 | CDK19 | 1.63957961 |
| 20 | MAP3K13 | 1.62468874 |
| 21 | ARAF | 1.60292532 |
| 22 | SIK3 | 1.58096055 |
| 23 | PRPF4B | 1.58035173 |
| 24 | PLK2 | 1.57951378 |
| 25 | MAP3K12 | 1.57125998 |
| 26 | NTRK2 | 1.56894332 |
| 27 | PAK6 | 1.56316081 |
| 28 | MARK1 | 1.53077397 |
| 29 | CCNB1 | 1.45952260 |
| 30 | SIK2 | 1.45269536 |
| 31 | MAP2K4 | 1.45082088 |
| 32 | CDK5 | 1.44888729 |
| 33 | FES | 1.43925492 |
| 34 | PRKD3 | 1.41045329 |
| 35 | LATS2 | 1.34298214 |
| 36 | NTRK1 | 1.28577405 |
| 37 | BMPR2 | 1.25919676 |
| 38 | TAOK1 | 1.24407454 |
| 39 | SGK2 | 1.15278748 |
| 40 | SGK223 | 1.11111495 |
| 41 | SGK494 | 1.11111495 |
| 42 | RAF1 | 1.10694434 |
| 43 | MAP3K2 | 1.07585000 |
| 44 | MAPK13 | 1.03037114 |
| 45 | AKT3 | 1.02921362 |
| 46 | PRKCG | 1.00262215 |
| 47 | PTK2B | 0.99295545 |
| 48 | CAMK2A | 0.97980092 |
| 49 | GRK5 | 0.97060403 |
| 50 | TYRO3 | 0.95465962 |
| 51 | CDK18 | 0.90520993 |
| 52 | SGK3 | 0.90362861 |
| 53 | CAMK2B | 0.87624532 |
| 54 | OXSR1 | 0.87399194 |
| 55 | SGK1 | 0.84991572 |
| 56 | STK38 | 0.82670111 |
| 57 | CAMK1 | 0.82361298 |
| 58 | CDK15 | 0.81952643 |
| 59 | STK11 | 0.78497869 |
| 60 | PKN1 | 0.77840568 |
| 61 | CDK14 | 0.77324106 |
| 62 | CDK11A | 0.71335428 |
| 63 | RIPK1 | 0.71064738 |
| 64 | DAPK3 | 0.67071579 |
| 65 | PAK3 | 0.66982947 |
| 66 | MARK2 | 0.66932509 |
| 67 | PRKCH | 0.66709069 |
| 68 | BRAF | 0.64182988 |
| 69 | PDPK1 | 0.63632189 |
| 70 | PDK1 | 0.62565469 |
| 71 | UHMK1 | 0.62080850 |
| 72 | MAPK7 | 0.59543519 |
| 73 | BCR | 0.58472831 |
| 74 | PINK1 | 0.57166979 |
| 75 | RET | 0.56516599 |
| 76 | MAPK4 | 0.55980253 |
| 77 | CAMK4 | 0.54277738 |
| 78 | MAP3K1 | 0.54272113 |
| 79 | NEK6 | 0.53416832 |
| 80 | MAP2K1 | 0.51890283 |
| 81 | TNK2 | 0.51675616 |
| 82 | FGR | 0.49675020 |
| 83 | PNCK | 0.49143157 |
| 84 | PRKG1 | 0.45728908 |
| 85 | RPS6KA3 | 0.45512263 |
| 86 | DYRK1A | 0.45084949 |
| 87 | PIK3CG | 0.44848936 |
| 88 | PRKCE | 0.43554265 |
| 89 | FYN | 0.43281839 |
| 90 | ALK | 0.42629135 |
| 91 | MUSK | 0.42365314 |
| 92 | MAPK12 | 0.41470992 |
| 93 | LIMK1 | 0.39738517 |
| 94 | MAPKAPK5 | 0.39625634 |
| 95 | CAMK2D | 0.37361587 |
| 96 | CSNK1D | 0.37361217 |
| 97 | ROCK2 | 0.36807692 |
| 98 | RPS6KB1 | 0.36117708 |
| 99 | PRKCB | 0.35322286 |
| 100 | MAPK10 | 0.34586989 |
| 101 | PRKCZ | 0.34463288 |
| 102 | MAP3K10 | 0.34171663 |
| 103 | ADRBK2 | 0.33331254 |
| 104 | NEK1 | 0.32706545 |
| 105 | CAMK2G | 0.31847481 |
| 106 | DMPK | 0.31040043 |
| 107 | MOS | 0.31006615 |
| 108 | CSNK1G2 | 0.30870306 |
| 109 | PRKACB | 0.29786799 |
| 110 | GSK3B | 0.29389133 |
| 111 | CSNK1A1 | 0.27920739 |
| 112 | MAP3K6 | 0.27727933 |
| 113 | MAPK8 | 0.27654126 |
| 114 | * PRKACA | 0.27434391 |
| 115 | FGFR2 | 0.27367029 |
| 116 | PRKCA | 0.26660548 |
| 117 | MAP3K7 | 0.25777334 |
| 118 | CDC42BPA | 0.24590423 |
| 119 | WNK1 | 0.22851089 |
| 120 | ADRBK1 | 0.22777647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.65652793 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 3.30014521 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.07134602 |
| 4 | Amphetamine addiction_Homo sapiens_hsa05031 | 3.01355903 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.96612580 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.95552807 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.87879282 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.73707784 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.66637676 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.63782970 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.45017708 |
| 12 | Cocaine addiction_Homo sapiens_hsa05030 | 2.26652122 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.26493439 |
| 14 | Renin secretion_Homo sapiens_hsa04924 | 2.10840672 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.03458798 |
| 16 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.89535214 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.87777771 |
| 18 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.85209912 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 1.83273242 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.81645259 |
| 21 | Long-term depression_Homo sapiens_hsa04730 | 1.77336747 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.74739930 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 1.74280343 |
| 24 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.70493491 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.64269695 |
| 26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.61648577 |
| 27 | Gap junction_Homo sapiens_hsa04540 | 1.50763811 |
| 28 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.41949965 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.39912650 |
| 30 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.32568097 |
| 31 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.23529239 |
| 32 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.23456349 |
| 33 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.13430087 |
| 34 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.11055316 |
| 35 | Glioma_Homo sapiens_hsa05214 | 1.09723360 |
| 36 | Phototransduction_Homo sapiens_hsa04744 | 1.09512207 |
| 37 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.04785328 |
| 38 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.02679970 |
| 39 | Melanogenesis_Homo sapiens_hsa04916 | 0.97544561 |
| 40 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.97360739 |
| 41 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.96151387 |
| 42 | Axon guidance_Homo sapiens_hsa04360 | 0.95263209 |
| 43 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.95082232 |
| 44 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.87521356 |
| 45 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.85233384 |
| 46 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.83389736 |
| 47 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.83310903 |
| 48 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79211933 |
| 49 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.77755780 |
| 50 | Alcoholism_Homo sapiens_hsa05034 | 0.76469130 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75014456 |
| 52 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.74402931 |
| 53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.74092112 |
| 54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72412421 |
| 55 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71902680 |
| 56 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.70336167 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68282876 |
| 58 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.66404263 |
| 59 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66243681 |
| 60 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.66210884 |
| 61 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64610583 |
| 62 | Circadian rhythm_Homo sapiens_hsa04710 | 0.62718152 |
| 63 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.60475749 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59627218 |
| 65 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56812157 |
| 66 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.56215839 |
| 67 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.55821564 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55719042 |
| 69 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.55648562 |
| 70 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53239434 |
| 71 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.52137314 |
| 72 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.50906727 |
| 73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.50680307 |
| 74 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49944870 |
| 75 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49928964 |
| 76 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46543397 |
| 77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45736952 |
| 78 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.45364703 |
| 79 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.45288378 |
| 80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44134496 |
| 81 | Alzheimers disease_Homo sapiens_hsa05010 | 0.39983278 |
| 82 | Tight junction_Homo sapiens_hsa04530 | 0.39500629 |
| 83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38334967 |
| 84 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38303490 |
| 85 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.35759193 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34516834 |
| 87 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.34174408 |
| 88 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.34172801 |
| 89 | Endometrial cancer_Homo sapiens_hsa05213 | 0.32671768 |
| 90 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.32449558 |
| 91 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.32074696 |
| 92 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31591143 |
| 93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.30765894 |
| 94 | Prion diseases_Homo sapiens_hsa05020 | 0.30442616 |
| 95 | Platelet activation_Homo sapiens_hsa04611 | 0.30369798 |
| 96 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30217641 |
| 97 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.30085995 |
| 98 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.29083935 |
| 99 | Bile secretion_Homo sapiens_hsa04976 | 0.28794742 |
| 100 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.28615919 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.28189239 |
| 102 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.27375472 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.25920703 |
| 104 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.25719480 |
| 105 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.24688979 |
| 106 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.24545353 |
| 107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.24132022 |
| 108 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.23063271 |
| 109 | Colorectal cancer_Homo sapiens_hsa05210 | 0.22715597 |
| 110 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.21892185 |
| 111 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.18924420 |

